Sage Therapeutics's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Sage Therapeutics is set to release its quarterly earnings on October 29, 2024. Analysts expect an EPS of $-1.55. Investors are keen on the company's guidance for future growth, as past performance showed a significant share price drop after missing EPS estimates.
October 28, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Sage Therapeutics is expected to report an EPS of $-1.55. Investors are focused on the company's guidance for future growth, as previous earnings miss led to a significant share price drop.
The upcoming earnings report is crucial for Sage Therapeutics, especially after a previous EPS miss led to a significant share price drop. Investors are particularly interested in the company's guidance for future growth, which could influence short-term stock price movements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100